Lusutrombopag TQ0223
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Lusutrombopag is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.
CAS nr:
1110766-97-6
Purity:
98%
Molecular Weight:
591,55
SMILES:
CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(c3cc(Cl)c(/C=C(\C)/C(O)=O)c(Cl)c3)=O)n2)c1OC
Formula:
C29H32Cl2N2O5S
Pathway:
Immunology/Inflammation,Proteases/Proteasome
Target:
Thrombopoietin Receptor,Thrombin
